Background: Jaundice is a common clinical condition in newbom occurring in approximately 60% of term and 80% of
contolled clinical trial enrolled sixty newborns with birth weight less than 1500 gram. They were divided into two groups: 1) Prophylactic group, in whom phototherapy was started within 24 hours of birth and continued for 7 days and 2) Control group in whom therapeutic phototherapy was started considering serum bilirubin level and other clinical conditions as per institutional guidelines. Mean value of total serum bilirubin (TSB), duration of phototherapy, the need for exchange transfusion and duration of hospital stay in both groups were analyzed. Results: The maximum mean TSB level in prophylactic gtoup was observed on 7th day and in control group it was observed on 3rd day of life. The total serum bilirubin levels were significantly lower in the 3rd and 5th days of life in the prophylactic group in comparison to contol group (P value 0.001). Total serum bilirubin level exceeded therapeutic range in 6 (21%) and 14 (50 %) newborns of the prophylactic group and control groups respectively (P value 0.026).No documented side effects of prophylactic phototherapy was observed. Conclusion: The use of prophylactic phototherapy for infants weighing less than 1500 gm is effective and safe when compared to ttre control group, considering satisfactory maintenance of low total serum bilirubin levels during first 7 days of life. There were no significant differences between both the groups regarding the mean gestational d}a, birth weight, occipitofrontal circumference(OFC), length, gender distribution, and mode of delivery ( Table-I ). 
